We found 5 drugmaker programs for ATTR Amyloidosis medicines and 6 charity funds (1 open at our last check). Tell us your insurance below and we'll show what to try first.
Help for ATTR Amyloidosis depends mostly on how you're covered. Pick the one that sounds like you. We'll name the funds and programs that fit, and what won't work, so you don't waste a phone call.
Independent foundations pay copays, coinsurance and sometimes insurance premiums for people who already have coverage. Funds open and close as donations come in, so each one shows what the foundation said on the date we checked.
Covers: Out-of-pocket costs for approved medications. Up to $5,500 a year.
Covers: Medical and medication costs.
Covers: Insurance premiums and copays.
Covers: Copays, coinsurance, deductibles and other health-related expenses.
Covers: Copays, premiums or other treatment costs.
Covers: Copays, premiums or other treatment costs.
Copay cards lower what people with private insurance pay. Federal rules bar them for Medicare, Medicaid and TRICARE. Free medicine programs are for people without enough coverage and usually have income limits. We read each program on the drugmaker's own site.
The Alnylam Assist Copay Program covers certain out-of-pocket costs for eligible commercially insured patients. Not for Medicare, Medicaid or other government insurance.
Programs may help if you have a delay or change in insurance coverage; a Case Manager checks eligibility after a Start Form.
The Alnylam Assist Patient Assistance Program provides treatment at no cost for eligible patients, mainly those who are uninsured.
After your doctor submits a Start Form, a Case Manager contacts you within 2 business days with a summary of your insurance benefits.
Most services start when your doctor submits the Alnylam Assist Start Form. Alnylam can also point uninsured or underinsured patients to independent foundations.
ForgingBridges Copay Assistance Program may lower out-of-pocket cost for Attruby to as little as $0 per month for eligible commercially insured patients.
ForgingBridges Patient Assistance Program may provide Attruby free. Income criteria apply; must be uninsured, have limited coverage, or have an appeal denial.
ForgingBridges QuickStart Program may provide Attruby free for a short time during an insurance delay, if eligible.
A Patient Access Liaison (PAL) helps connect patients to financial support, including referrals to independent charitable foundations.
ForgingBridges is BridgeBio's support program. Eligibility criteria and terms apply to all programs.
The Alnylam Assist Copay Program covers certain out-of-pocket costs for eligible commercially insured patients. Not for Medicare, Medicaid or other government insurance.
Programs may help if you have a delay or change in insurance coverage; a Case Manager checks eligibility after a Start Form.
The Alnylam Assist Patient Assistance Program provides treatment at no cost for eligible patients, mainly those who are uninsured.
After your doctor submits a Start Form, a Case Manager contacts you within 2 business days with a summary of your insurance benefits.
Most services start when your doctor submits the Alnylam Assist Start Form. Alnylam can also point uninsured or underinsured patients to independent foundations.
Co-Pay Savings Program: eligible commercially insured patients may pay as little as $0 per month; $10,000-$60,000 maximum benefit per calendar year.
Pfizer Patient Assistance Program through VyndaLink may help eligible uninsured or government-insured patients when other options aren't available.
A VynAssist Access Care Manager helps patients and caregivers understand coverage and financial support options.
Covers VYNDAMAX. Pfizer stopped supplying VYNDAQEL in the U.S. as of December 31, 2025; VyndaLink offerings still apply to patients prescribed VYNDAQEL. Copay card excludes Medicare, Medicaid, TRICARE, VA and other government programs; copay questions: 1-888-222-8475. Patients must apply to and be denied by other sources before the Pfizer PAP considers them.
WAINUA Savings Program: eligible commercially insured patients may pay as little as $0 per month, up to a yearly maximum set by AstraZeneca. Your plan must cover Wainua. Not for Medicare Part D, Medicaid, Medigap, VA, TRICARE or other government insurance. Covers the drug only, not office visits.
AstraZeneca Access 360, part of the WAINUA WAY program, checks your insurance coverage, explains out-of-pocket costs and helps you find financial assistance, even if you have no insurance or were denied coverage. Call 1-844-2-WAINUA (1-844-292-4682), Monday to Friday, 8 AM to 6 PM ET.
The AZ&Me Prescription Savings Program includes Wainua and provides AstraZeneca medicines at no cost to people who qualify, such as people without insurance and some people on Medicare Part B or D. Eligibility rules apply; call 1-800-292-6363.
WAINUA WAY is AstraZeneca's support program for Wainua. AstraZeneca Access 360 (part of WAINUA WAY) answers insurance and cost questions at 1-844-2-WAINUA (1-844-292-4682), Monday to Friday, 8 AM to 6 PM ET, and a Patient Education Manager is a dedicated contact during treatment. The 1-800-236-9933 number on the label is AstraZeneca's general Information Center. Open charity funds for amyloidosis are listed below.
Most of these programs start with one call, and having these ready makes it shorter. Tick them off as you go. Nothing here is saved or sent anywhere.
Call the drugmaker's support line first. Its case managers check your benefits and often fill out forms with your doctor. If a charity fund is closed, sign up on the foundation's page to hear when it reopens. Most programs need renewing every year, and many copay cards reset in January.
Yes. Trial Friend lists 5 drugmaker programs for ATTR Amyloidosis medicines and 6 charity funds, 1 of them open at our last check. We checked every one at the source on or before October 19, 2026. Which ones fit depends on your insurance. Copay cards are for people with private insurance, charity funds usually need some insurance, and free medicine programs are for people without enough coverage.
No. Federal rules bar drugmaker copay cards for drugs paid by Medicare, Medicaid or TRICARE. For ATTR Amyloidosis, 1 charity fund on this page accepts Medicare (1 open at our last check), and 2 drugmaker free medicine programs name Medicare patients among those who may qualify. In 2026, Medicare Part D also caps yearly out-of-pocket costs for covered drugs at $2,100.
At our last check, TotalAssist's Amyloidosis fund was open to new applicants. Funds open and close as donations come in, so check the foundation's page before you apply.
Of the drugmaker programs for ATTR Amyloidosis medicines, 5 offer free medicine to people without insurance who qualify, usually with income limits. Most charity funds pay copays and premiums, so they need some insurance. The drugmaker's support line can also check whether you qualify for coverage you don't have yet.
How we check: drugmaker programs come only from each drugmaker's own pages. Fund status is copied from each foundation's list (TotalAssist, NORD RareCare, The Assistance Fund, HealthWell Foundation) on the date shown. Programs change, so confirm with the program before you rely on it. Trial Friend shares information, not financial, legal or medical advice, and each program decides who qualifies. See something wrong? Email jason@trialfriend.com.
